189 related articles for article (PubMed ID: 29524457)
1. Factors Related to Nevus-Associated Cutaneous Melanoma: A Case-Case Study.
Pandeya N; Kvaskoff M; Olsen CM; Green AC; Perry S; Baxter C; Davis MB; Mortimore R; Westacott L; Wood D; Triscott J; Williamson R; Whiteman DC
J Invest Dermatol; 2018 Aug; 138(8):1816-1824. PubMed ID: 29524457
[TBL] [Abstract][Full Text] [Related]
2. Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis.
Lee EY; Williamson R; Watt P; Hughes MC; Green AC; Whiteman DC
Int J Cancer; 2006 Aug; 119(3):636-42. PubMed ID: 16572428
[TBL] [Abstract][Full Text] [Related]
3. Solar elastosis and cutaneous melanoma: a site-specific analysis.
Kvaskoff M; Pandeya N; Green AC; Perry S; Baxter C; Davis MB; Mortimore R; Westacott L; Wood D; Triscott J; Williamson R; Whiteman DC
Int J Cancer; 2015 Jun; 136(12):2900-11. PubMed ID: 25403328
[TBL] [Abstract][Full Text] [Related]
4. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma.
Purdue MP; From L; Armstrong BK; Kricker A; Gallagher RP; McLaughlin JR; Klar NS; Marrett LD;
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2015-22. PubMed ID: 16103454
[TBL] [Abstract][Full Text] [Related]
5. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
6. Histologic and Phenotypic Factors and MC1R Status Associated with BRAF(V600E), BRAF(V600K), and NRAS Mutations in a Community-Based Sample of 414 Cutaneous Melanomas.
Hacker E; Olsen CM; Kvaskoff M; Pandeya N; Yeo A; Green AC; Williamson RM; Triscott J; Wood D; Mortimore R; Hayward NK; Whiteman DC
J Invest Dermatol; 2016 Apr; 136(4):829-837. PubMed ID: 26807515
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study.
Carli P; Massi D; Santucci M; Biggeri A; Giannotti B
J Am Acad Dermatol; 1999 Apr; 40(4):549-57. PubMed ID: 10188672
[TBL] [Abstract][Full Text] [Related]
8. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
9. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
10. Nevus-associated melanomas: clinicopathologic features.
Shitara D; Nascimento MM; Puig S; Yamada S; Enokihara MM; Michalany N; Bagatin E
Am J Clin Pathol; 2014 Oct; 142(4):485-91. PubMed ID: 25239415
[TBL] [Abstract][Full Text] [Related]
11. The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population.
Hacker E; Hayward NK; Dumenil T; James MR; Whiteman DC
J Invest Dermatol; 2010 Jan; 130(1):241-8. PubMed ID: 19571821
[TBL] [Abstract][Full Text] [Related]
12. Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.
Karram S; Novy M; Saroufim M; Loya A; Taraif S; Houreih MA; Rauscher B; Habib RH; Oberkanins C; Khalifeh I
Am J Dermatopathol; 2013 Jun; 35(4):412-8. PubMed ID: 23051629
[TBL] [Abstract][Full Text] [Related]
13. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas.
Richmond-Sinclair NM; Lee E; Cummings MC; Williamson R; Muller K; Green AC; Hayward NK; Whiteman DC
Melanoma Res; 2008 Oct; 18(5):336-45. PubMed ID: 18781132
[TBL] [Abstract][Full Text] [Related]
14. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features.
Kiuru M; Tartar DM; Qi L; Chen D; Yu L; Konia T; McPherson JD; Murphy WJ; Fung MA
J Am Acad Dermatol; 2018 Aug; 79(2):221-229. PubMed ID: 29653212
[TBL] [Abstract][Full Text] [Related]
15. De Novo and Nevus-Associated Melanomas: Different Histopathologic Characteristics but Similar Survival Rates.
Tas F; Erturk K
Pathol Oncol Res; 2020 Oct; 26(4):2483-2487. PubMed ID: 32572820
[TBL] [Abstract][Full Text] [Related]
16. Nevus-associated melanoma: facts and controversies.
Pampena R; Lai M; Piana S; Lallas A; Pellacani G; Longo C
G Ital Dermatol Venereol; 2020 Feb; 155(1):65-75. PubMed ID: 32100974
[TBL] [Abstract][Full Text] [Related]
17. De novo melanoma and melanoma arising from pre-existing nevus: in vivo morphologic differences as evaluated by confocal microscopy.
Longo C; Rito C; Beretti F; Cesinaro AM; Piñeiro-Maceira J; Seidenari S; Pellacani G
J Am Acad Dermatol; 2011 Sep; 65(3):604-614. PubMed ID: 21715047
[TBL] [Abstract][Full Text] [Related]
18. Is there more than one road to melanoma?
Rivers JK
Lancet; 2004 Feb; 363(9410):728-30. PubMed ID: 15005091
[TBL] [Abstract][Full Text] [Related]
19. MC1R germline variants confer risk for BRAF-mutant melanoma.
Landi MT; Bauer J; Pfeiffer RM; Elder DE; Hulley B; Minghetti P; Calista D; Kanetsky PA; Pinkel D; Bastian BC
Science; 2006 Jul; 313(5786):521-2. PubMed ID: 16809487
[TBL] [Abstract][Full Text] [Related]
20. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
